Physician

Steve K Nam, M.D.

According to 2025 Medicare claims, Steve Nam, M.D. (NPI: 1174788061) practices internal medicine in the Canton-Massillon, OH market, with the plurality of this provider's patient population coming from Stark, OH. This provider's primary affiliated billing organization is STARK COUNTY PHYSICIANS LLC (NPI: 1154695815; TIN: 45-4643957) and primary practice location at 44718-2819. Nam is affiliated with the IHC Quality Partners, LLC (ACO ID: A2833), participating under the MSSP model.

Nam's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 336 traditional Medicare patients, billed 2,732 HCPCS/CPT codes, and received $171,809 in Medicare payments. The top billing code was G0439 (Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit). Part D data shows 8,467 prescription claims across 978 beneficiaries totaling $930,305 in drug costs, led by Eliquis (Apixaban). DME data shows 228 claims. Open Payments data shows 163 records totaling $2,365. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $77,428 to $171,809. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $6,050 and ending at $16,772.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	337	1,550	$77,428
2016	398	2,078	$96,813
2017	444	3,281	$150,682
2018	458	2,789	$129,958
2019	451	2,676	$134,879
2020	414	2,117	$117,792
2021	430	2,348	$161,164
2022	456	2,563	$167,287
2023	392	3,173	$193,590
2024	336	2,732	$171,809

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	675	16,227	$1,082,224
2016	678	17,279	$1,099,971
2017	907	20,846	$1,476,249
2018	852	17,345	$1,488,380
2019	901	15,062	$1,507,525
2020	919	15,512	$1,551,983
2021	943	13,298	$1,403,191
2022	1,026	14,379	$1,719,293
2023	1,028	15,689	$1,997,487
2024	978	8,467	$930,305

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	12	85	$4,168
2016	12	121	$3,689
2017	13	296	$7,019
2018	116	429	$11,674
2019	64	312	$5,571
2020	61	295	$9,033
2021	84	416	$16,272
2022	85	346	$14,768
2023	33	349	$15,808
2024	25	228	$11,594

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
G0439	Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit	237	237	$122
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	238	510	$81
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	276	567	$56
G0008	Administration of influenza virus vaccine	102	104	$30
G0444	Annual depression screening, 5 to 15 minutes	179	179	$17

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	123	6,628	$126,639
Jardiance	Empagliflozin	68	3,900	$73,937
Xarelto	Rivaroxaban	84	3,486	$63,739
Ozempic	Semaglutide	49	2,030	$62,150
Mounjaro	Tirzepatide	39	1,266	$47,589

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	N/R	23	$6,086
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	29	$2,061
E0601	Continuous positive airway pressure (cpap) device	Y	N/R	34	$1,024
A7034	Nasal interface (mask or cannula type) used with positive airway pressure device, with or without head strap	N	N/R	17	$884
A4253	Blood glucose test or reagent strips for home blood glucose monitor, per 50 strips	N	N/R	25	$413

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	163	$2,365	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Steve K. Nam, M.D.?

Tedicare shows public-source Medicare data for Steve K. Nam, M.D. (NPI 1174788061), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Steve K. Nam, M.D. have ACO affiliation data?

Steve K. Nam, M.D. is shown with ACO affiliation data for IHC Quality Partners, LLC (MSSP, ACO ID A2833).

What billing organization is linked to Steve K. Nam, M.D.?

Steve K. Nam, M.D. is linked to STARK COUNTY PHYSICIANS LLC (billing NPI 1154695815) in the available physician profile data.

Does Steve K. Nam, M.D. have Open Payments data?

Steve K. Nam, M.D. has 163 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.